Viskas, kas tau svarbu, vienoje vietoje
Sek srautus: tinklaraščius, naujienas, RSS ir daugiau. Lengvas būdas skaityti ir įsisavinti pasirinktą turinį.
Gauti FeederOnkologija RSS kanalai
Feeder naudotojų dažniausiai sekami Onkologija RSS kanalai, įskaitant ScienceDirect Publication: Nuclear Medicine and Biology, JNCI: Journal of the National Cancer Institute Advance Access ir ScienceDirect Publication: Cancer Cell. Nukopijuokite kanalo URL arba sekite juos nemokamai per Feeder.
Susijusios temos
Sveikata RSS kanalai Klinikiniai tyrimai RSS kanalai Medicininiai tyrimai RSS kanalai Psichikos sveikata RSS kanalai Psichologija RSS kanalai Visuomenės sveikata RSS kanalai Farmacija RSS kanalai
Pasiūlyti pataisąbioRxiv Subject Collection: Cancer Biology
This feed contains articles for bioRxiv Subject Collection "Cancer Biology"
Business Wire - News by Company: Incyte Corporation
Business Wire - The global leader in news distribution
Annual Reviews: Annual Review of Cancer Biology: Table of Contents
Please follow the links to view the content.
Cancer Gene Therapy
<em>Cancer Gene Therapy</em> is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair. <em>Cancer Gene Therapy</em> publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Articles published include the fields of drug resist
Press Releases | Bicycle Therapeutics (GU)
investors.bicycletherapeutics.com
The Investor Relations website contains information about Bicycle Therapeutics's business for stockholders, potential investors, and financial analysts.